Globe Life

GL US Financials Life & Health Insurance
S&P 500
$171.17
+0.22%
Delayed · cached 15 min

Fair value analysis

GL
Globe Life
FinancialsLife & Health Insurance
$171.17
Close used for this calculation
$256.07Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
68/100
Profitability19/25
Returns14/25
Balance Sheet17/25
Efficiency18/25
Growth14/25
Strong
Quality radar
68Prof.19/25Ret.14/25Eff.18/25B.Sht17/25Growth14/25

Consensus fair value

$256.07
Below FV
▲ +49.6% against the close used
Model range $157.30 – $301.56
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$157.30Fair value$256.07Bull$301.56
FairClose
52-week traded range
52W low $130.3752W high $186.02

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Globe Life closed at $171.17, 33.2% below the consensus fair value of $256.07 drawn from 8 valuation models.

Financial DNA score 68/100 — Strong. P/E of 12.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$301.56
+76.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$157.30
-8.1%
√(22.5 × EPS × BVPS)
EPS=14.07, BVPS=78.16 · outside Graham range (P/E 12.2, P/B 2.2) — asset-light, treat as a rough floor
P/E Fair Value
$281.40
+64.4%
EPS × 20x (sector P/E)
EPS=14.07, Sector P/E=20x
Peter Lynch (PEG)
$167.29
-2.3%
EPS × Growth% (PEG = 1 is fair)
EPS=14.07, g=11.9%
EV/EBITDA
$253.16
+47.9%
(EBITDA × 15.9x − Net Debt) ÷ Shares
EBITDA=1.47B
Book Value (P/B)
$251.28
+46.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=78.16, ROE=18.9%, g=6%, r=10%
Reverse DCF
$171.17
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 0.4% | Historical: 11.9%
Margin of Safety
$185.07
+8.1%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=246.75, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.